Casandra Sajkalski, The Canadian Press
Sunday, December 2, 2018 9:38 AM AST Published
Toronto – Aishwarya suffers from continuous backache, so when his doctor suggested that he saw a cannabis expert, he was upset.
At the age of 64, with marijuana, there was no joy or otherwise experienced, but the knowledge of the herb's pain-relief potential was reported and she was eager to avoid opioids.
He was called a cannabis clinic and had a doctor with questions. He was not happy with what he heard.
In a recent information session on medical marijuana in Tosau, Basu complained that "he does not seem to get too much information".
"The problem I have is that there is no data on the interaction I am taking in all the medicines I have, I am diabetic, I have received blood pressure, I am on three different allergic medicines. It's a lot of drugs I'm on. "
Basu left the clinic with the authenticity of buying medical cannabis oil, but did not buy it even after two months. She does not think that she will do it soon.
Mississauga, Ontario, resident says, "I'm really, really afraid … to try this, because I do not want any reactions and I do not want to fall. That's my biggest concern."
Candace Chartier, CEO of the Ontario Long-Term Care Association, says that there is a lot of interest in cannabis among older people but there are many questions.
In Ontario's long-term care facilities, it is a major reason for the group to start a six-month pilot program to track and monitor the effects of the use of medical cannabis in 500 scientists.
Chartier notes that many canvassers have already used medical cannabis by many residents, who say that members of staff and family members have already reported positive results.
"It affects, that time is less necessary to take care of the residents …. Those carers see the difference in the level of pain, he says."
"We know that they work on a small scale and that's why we're excited to do this much larger."
Chartier says that the OLTCA will integrate the program and the cannabis company will develop screening equipment for nurses, pharmacists, doctors and caregivers in connection with Canopy Growth, which supplies marijuana.
The results show that in the direction of the regional facilities can focus: "It will become a clinical support tool so that everyone in the province can benefit from it."
Meanwhile, the same six-month study was launched on Monday, which involves the BC-based cannabis company Tillai, which sets the number of patients under the age of 50 years for medical marijuana effect, the probability of pain, and quality of life check.
Phillip Lucas, Tillre's global patient research and use director says that this study will begin in Sarania, Ontario and in the end of 2019 it will expand to more clinics in British Columbia and New Brunswick.
He expects 600 to 1,000 patients to sign up, and there is a shortage of detailed data on how older people are using cannabis and results.
Lukas says, "There are no subsequent trekking, potential studies, which are tracking the effects of medical cannabis over time."
Tillare studied in Ontario, Canabas specialist in Sarnia, Dr. Black Pearson is specializing in cannabidotherapy for senior people, including people living in long-term care facilities.
Pearson says that cannabis is not for everyone, but it is estimated that 60 to 70 percent of the patients try medical cannabis under their care, which looks at some types of improvement.
"Frequently, I can treat a genetic patient with cannabis oil and as a result, reducing potentially two or three other drugs, because it is multimodal," Pearson says.
"So we can deal with pain, anxiety and sleep with one thing against three or four different drugs."
Therapies say that reducing the drugs does not only increase the quality of life for the patient, but "quality of workplace for staff" on long-term care facilities ".
"It can possibly reduce the time of administration of the drug management and cut about half of it," he notes.
Canopie's Chief Medical Officer Dr. Mark Vere noted that medical cannabis research focuses on childhood brains and chronic pain and middle-aged people with spastic seizures.
The Montreal-based pain specialist says that "the elderly have not received much attention and it is a good reason to think that they can handle cannabines in a different way than a small person." Marijuana in Canada
"They may need small doses, they can give metabolism more slowly."
He saw a major advantage in routing research in long-term care facilities.
"He has very strong tracking systems for the use of medicines for neurogenic symptoms for dry and pain scores, so they are really very accustomed to track the health of their residents."
Basu says that he is in search of hand-length research that will evaluate the use of medical cannabis for seniors indiscriminately, it is generally skeptical of the study involved in the private sector. But he focuses more on the concerns of the seniors.
"It's all about teaching," she says. "I think the industry needs to do a lot."